Dr. Schoenfeld on Low-Dose Radiation Plus Immunotherapy in Head and Neck CancerOncLiveJonathan D. Schoenfeld, MD, MPhil, MPH, director, melanoma radiation oncology, physician, assistant professor of radiation oncology, Harvard Medical School, Dana-Farb… Continue reading
|
Immunotherapy Tops Cancer Advances Again
MedPage Today The transformative effect of immunotherapy on cancer remained the top cancer advance for the second consecutive year, according to the American Society of Clinical Oncology (ASCO). “Immunotherapy 2.0″ topped all other advances during 2016, according … ASCO Report Names Advanced of the Year: Immunotherapy 2.0LWW Journals (blog) |
|
Immunotherapy Tops Cancer Advances Again
MedPage Today The transformative effect of immunotherapy on cancer remained the top cancer advance for the second consecutive year, according to the American Society of Clinical Oncology (ASCO). “Immunotherapy 2.0″ topped all other advances during 2016, according … ASCO Report Names Advanced of the Year: Immunotherapy 2.0LWW Journals (blog) |
StreetInsider.com |
BioMarin Pharma (BMRN) Reports PRIME Regulatory Support for BMN 270 Gene Therapy in Hemophilia A
StreetInsider.com BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the European Medicines Agency (EMA) has granted access to its Priority Medicines (PRIME) regulatory initiative for the company’s investigational gene therapy treatment for severe … |